Vanda Pharmaceuticals (VNDA) Prepares to Explore Sale - Reuters
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
(Updated - September 22, 2016 3:46 PM EDT)
Vanda Pharmaceuticals (NASDAQ: VNDA) is preparing to consider strategic alternatives including a potential sale, according to Reuters, citing people familiar. The company is said to be holding conversations with investment banks about naming a financial adviser to help it review options.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Dr Pepper Snapple Group (DPS) Said in Talks to Buy Bai Brands - Reuters
- Vornado Realty Trust (VNO) Said to Mull Selling Washington Unit to JBG Via Spinoff - Bloomberg
- 21st Century Fox (FOXA) Won't Bid for Viacom (VIAB)
Create E-mail Alert Related CategoriesHot M&A, Mergers and Acquisitions, Rumors, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!